Clinical Trial Update: Parathyroid Adenoma Detection With Rubidium-82 Imaging

View source ↗

Summary

A clinical trial is evaluating Rubidium-82 PET imaging to detect parathyroid adenomas in primary hyperparathyroidism; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism Primary
• Parathyroid Adenomas

Drugs mentioned

• Rubidium-82 chloride (Rubidium-82 chloride)

Snippet

Sponsor: Matthieu Pelletier-Galarneau, MD MSc | Conditions: Parathyroid Adenomas, Hyperparathyroidism, Primary | Status: NOT_YET_RECRUITING